据近期出版的《国立癌症研究所杂志》(JNCI)刊文报道,研究证实患有乳腺癌的绝经期妇女接受含有雌激素和孕激素的激素替代治疗(HRT)时,其乳腺癌复发的风险增高。来自于瑞典斯德哥尔摩Karolinska大学医院和研究中心的Eva von Schoultz博士及其同事报道说,瑞典的两项新的绝经期激素治疗与非绝经期激素治疗早期乳腺癌妇女的对比研究在乳腺癌的复发风险上得出不同的结论;研究人员对这两项研究的设计 A study published in the recently published JNCI report confirmed the risk of breast cancer recurrence in postmenopausal women with breast cancer who received hormone replacement therapy (HRT) with estrogen and progesterone Increase. Eva von Schoultz, PhD, from Karolinska University Hospital and Research Center in Stockholm, Sweden, and colleagues report that two new Swedish studies comparing menopausal and non-menopausal hormone therapies for early breast cancer women are at risk of breast cancer recurrence Come to different conclusions; researchers on the design of these two studies